vasomotor symptoms (menopause)
Women's health · 2025–2025
1decision
1medicine
1carried consumer input
26individual submissions
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| fezolinetant Moderate to severe vasomotor symptoms (VMS) associated with menopause in patients unsuitable for menopausal hormone therapy (MHT) due to contraindication,… | Nov 2025 | Recommended | 26 individuals TBC Bayer Australia |
Who spoke
TBC Bayer Australia
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 1 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.